drugset / Trial / NCT00005001

Safety and Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)

NCT00005001

Phase 2 Completed 40 enrolled Agouron Pharmaceuticals
Double-blindTreatment

Summary

The purpose of this study is to see if giving HIV-positive patients an HIV vaccine plus anti-HIV drugs can help lower HIV levels in the blood (viral load).

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Remune Vaccine